
Company Number
05091128
Next Accounts
May 2025
Shareholders
optinose as
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
10 fleet place, london, EC4M 7RB
Website
www.optinose.comPomanda estimates the enterprise value of OPTINOSE UK LIMITED at £363.3k based on a Turnover of £402.4k and 0.9x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of OPTINOSE UK LIMITED at £332.1k based on an EBITDA of £92.2k and a 3.6x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of OPTINOSE UK LIMITED at £0 based on Net Assets of £-31k and 1.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Optinose Uk Limited is a dissolved company that was located in london, EC4M 7RB with a Companies House number of 05091128. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2004, it's largest shareholder was optinose as with a 100% stake. The last turnover for Optinose Uk Limited was estimated at £402.4k.
Pomanda's financial health check has awarded Optinose Uk Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
0 Regular
7 Weak
Size
annual sales of £402.4k, make it smaller than the average company (£2.8m)
£402.4k - Optinose Uk Limited
£2.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -16%, show it is growing at a slower rate (11.8%)
-16% - Optinose Uk Limited
11.8% - Industry AVG
Production
with a gross margin of 30.7%, this company has a higher cost of product (52.1%)
30.7% - Optinose Uk Limited
52.1% - Industry AVG
Profitability
an operating margin of 7% make it more profitable than the average company (-12.7%)
7% - Optinose Uk Limited
-12.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (40)
2 - Optinose Uk Limited
40 - Industry AVG
Pay Structure
on an average salary of £136.3k, the company has a higher pay structure (£70.4k)
£136.3k - Optinose Uk Limited
£70.4k - Industry AVG
Efficiency
resulting in sales per employee of £201.2k, this is more efficient (£122.8k)
£201.2k - Optinose Uk Limited
£122.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Optinose Uk Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Optinose Uk Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Optinose Uk Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (31 weeks)
3 weeks - Optinose Uk Limited
31 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 107.4%, this is a higher level of debt than the average (54.7%)
107.4% - Optinose Uk Limited
54.7% - Industry AVG
Optinose Uk Limited's latest turnover from December 2020 is £402.4 thousand and the company has net assets of -£31 thousand. According to their latest financial statements, Optinose Uk Limited has 2 employees and maintains cash reserves of £29 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 402,400 | 439,130 | 985,125 | 671,372 | 715,927 | 364,232 | 364,567 | 482,796 | 465,326 | 487,628 | 492,461 | 479,805 |
Other Income Or Grants | ||||||||||||
Cost Of Sales | 278,845 | 312,913 | 803,141 | 465,053 | 491,870 | 212,947 | 221,501 | 318,408 | 303,277 | 325,624 | 188,772 | |
Gross Profit | 123,555 | 126,217 | 181,984 | 206,319 | 224,057 | 151,285 | 143,066 | 164,388 | 162,049 | 162,004 | 303,689 | |
Admin Expenses | 95,366 | 91,399 | 80,207 | 199,185 | 166,264 | 140,826 | 160,033 | 172,355 | 171,353 | 174,123 | 312,285 | |
Operating Profit | 28,189 | 34,818 | 101,777 | 7,134 | 57,793 | 10,459 | -16,967 | -7,967 | -9,304 | -12,119 | -8,596 | -10,432 |
Interest Payable | 55,040 | 88,779 | 18,729 | |||||||||
Interest Receivable | 11,760 | 39,554 | 219 | |||||||||
Pre-Tax Profit | -15,091 | -14,407 | 83,267 | 7,134 | 57,793 | 10,459 | -16,967 | -7,967 | -9,304 | -12,119 | -8,596 | -10,432 |
Tax | ||||||||||||
Profit After Tax | -15,091 | -14,407 | 83,267 | 7,134 | 57,793 | 10,459 | -16,967 | -7,967 | -9,304 | -12,119 | -8,596 | -10,432 |
Dividends Paid | ||||||||||||
Retained Profit | -15,091 | -14,407 | 83,267 | 7,134 | 57,793 | 10,459 | -16,967 | -7,967 | -9,304 | -12,119 | -8,596 | -10,432 |
Employee Costs | 272,681 | 289,831 | 60,642 | 59,369 | 103,732 | 73,232 | 83,120 | 218,985 | ||||
Number Of Employees | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
EBITDA* | 92,185 | 98,773 | 152,401 | 10,619 | 57,793 | 10,459 | -16,967 | -7,301 | -8,163 | -10,978 | -7,740 | -10,432 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 136,879 | 200,875 | 264,830 | 162,048 | 666 | 1,807 | 2,948 | |||||
Intangible Assets | ||||||||||||
Investments & Other | ||||||||||||
Debtors (Due After 1 year) | ||||||||||||
Total Fixed Assets | 136,879 | 200,875 | 264,830 | 162,048 | 666 | 1,807 | 2,948 | |||||
Stock & work in progress | ||||||||||||
Trade Debtors | ||||||||||||
Group Debtors | 201,911 | 177,889 | 984,998 | 3,370 | ||||||||
Misc Debtors | 53,346 | 56,940 | 77,317 | 167,758 | 118,750 | 5,119 | 3,977 | 3,639 | 11,897 | 9,682 | 3,705 | 4,017 |
Cash | 29,019 | 75,092 | 49,333 | 89,578 | 29,190 | 42,659 | 44,159 | 28,153 | 21,989 | 10,631 | 20,290 | 39,062 |
misc current assets | 44 | |||||||||||
total current assets | 284,320 | 309,921 | 1,111,648 | 257,336 | 151,310 | 47,778 | 48,136 | 31,792 | 33,886 | 20,313 | 23,995 | 43,079 |
total assets | 421,199 | 510,796 | 1,376,478 | 419,384 | 151,310 | 47,778 | 48,136 | 31,792 | 34,552 | 22,120 | 26,943 | 43,079 |
Bank overdraft | ||||||||||||
Bank loan | ||||||||||||
Trade Creditors | 1,401 | 103,947 | 51,610 | 4,408 | 3,018 | 3,114 | 4,129 | 31,976 | 4,370 | 3,865 | ||
Group/Directors Accounts | 452,200 | 476,276 | 1,202,175 | 386,476 | 118,398 | 178,109 | 188,097 | 158,216 | 136,564 | 102,441 | 125,621 | 123,634 |
other short term finances | ||||||||||||
hp & lease commitments | ||||||||||||
other current liabilities | 49,029 | 71,859 | 117,678 | 73,206 | 14,958 | 17,177 | 13,651 | 29,081 | 13,621 | 10,751 | 20,783 | |
total current liabilities | 452,200 | 526,706 | 1,377,981 | 504,154 | 243,214 | 197,475 | 208,292 | 174,981 | 169,774 | 148,038 | 140,742 | 148,282 |
loans | ||||||||||||
hp & lease commitments | ||||||||||||
Accruals and Deferred Income | ||||||||||||
other liabilities | ||||||||||||
provisions | ||||||||||||
total long term liabilities | ||||||||||||
total liabilities | 452,200 | 526,706 | 1,377,981 | 504,154 | 243,214 | 197,475 | 208,292 | 174,981 | 169,774 | 148,038 | 140,742 | 148,282 |
net assets | -31,001 | -15,910 | -1,503 | -84,770 | -91,904 | -149,697 | -160,156 | -143,189 | -135,222 | -125,918 | -113,799 | -105,203 |
total shareholders funds | -31,001 | -15,910 | -1,503 | -84,770 | -91,904 | -149,697 | -160,156 | -143,189 | -135,222 | -125,918 | -113,799 | -105,203 |
Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||
Operating Profit | 28,189 | 34,818 | 101,777 | 7,134 | 57,793 | 10,459 | -16,967 | -7,967 | -9,304 | -12,119 | -8,596 | -10,432 |
Depreciation | 63,996 | 63,955 | 50,624 | 3,485 | 666 | 1,141 | 1,141 | 856 | ||||
Amortisation | ||||||||||||
Tax | ||||||||||||
Stock | ||||||||||||
Debtors | 20,428 | -827,486 | 894,557 | 45,638 | 117,001 | 1,142 | 338 | -8,258 | 2,215 | 5,977 | -312 | 4,017 |
Creditors | -1,401 | -102,546 | 103,947 | -51,610 | 47,202 | 1,390 | -96 | -1,015 | -27,847 | 27,606 | 505 | 3,865 |
Accruals and Deferred Income | -49,029 | -22,830 | -45,819 | 44,472 | 58,248 | -2,219 | 3,526 | -15,430 | 15,460 | 2,870 | -10,032 | 20,783 |
Deferred Taxes & Provisions | ||||||||||||
Cash flow from operations | 21,327 | 800,883 | -684,028 | -42,157 | 46,242 | 8,488 | -13,875 | -15,488 | -22,765 | 13,521 | -16,955 | 10,199 |
Investing Activities | ||||||||||||
capital expenditure | -111,651 | -165,533 | ||||||||||
Change in Investments | ||||||||||||
cash flow from investments | -111,651 | -165,533 | ||||||||||
Financing Activities | ||||||||||||
Bank loans | ||||||||||||
Group/Directors Accounts | -24,076 | -725,899 | 815,699 | 268,078 | -59,711 | -9,988 | 29,881 | 21,652 | 34,123 | -23,180 | 1,987 | 123,634 |
Other Short Term Loans | ||||||||||||
Long term loans | ||||||||||||
Hire Purchase and Lease Commitments | ||||||||||||
other long term liabilities | ||||||||||||
share issue | ||||||||||||
interest | -43,280 | -49,225 | -18,510 | |||||||||
cash flow from financing | -67,356 | -775,124 | 797,189 | 268,078 | -59,711 | -9,988 | 29,881 | 21,652 | 34,123 | 1,987 | 28,863 | |
cash and cash equivalents | ||||||||||||
cash | -46,073 | 25,759 | -40,245 | 60,388 | -13,469 | -1,500 | 16,006 | 6,164 | 11,358 | -9,659 | -18,772 | 39,062 |
overdraft | ||||||||||||
change in cash | -46,073 | 25,759 | -40,245 | 60,388 | -13,469 | -1,500 | 16,006 | 6,164 | 11,358 | -9,659 | -18,772 | 39,062 |
Perform a competitor analysis for optinose uk limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in EC4M area or any other competitors across 12 key performance metrics.
OPTINOSE UK LIMITED group structure
Optinose Uk Limited has no subsidiary companies.
Ultimate parent company
OPTINOSE INC
#0100491
OPTINOSE AS
#0030499
2 parents
OPTINOSE UK LIMITED
05091128
Optinose Uk Limited currently has 2 directors. The longest serving directors include Ms Helena Djupesland (Apr 2004) and Mr Michael Berkey (Mar 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Helena Djupesland | Norway | 66 years | Apr 2004 | - | Director |
Mr Michael Berkey | 49 years | Mar 2020 | - | Director |
P&L
December 2020turnover
402.4k
-8%
operating profit
28.2k
-19%
gross margin
30.8%
+6.83%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2020net assets
-31k
+0.95%
total assets
421.2k
-0.18%
cash
29k
-0.61%
net assets
Total assets minus all liabilities
company number
05091128
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
April 2004
age
21
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2020
previous names
N/A
accountant
-
auditor
SYGMA
address
10 fleet place, london, EC4M 7RB
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 6 charges/mortgages relating to optinose uk limited. Currently there are 0 open charges and 6 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for OPTINOSE UK LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|